ASND - Ascendis Pharma AS - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ASND is currently covered by 13 analysts with an average price target of $272.96. This is a potential upside of $58.19 (27.09%) from yesterday's end of day stock price of $214.77.

Ascendis Pharma AS's activity chart (see below) currently has 333 price targets and 226 ratings on display. The stock rating distribution of ASND is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 81.11% with an average time for these price targets to be met of 538.36 days.

Highest price target for ASND is $280, Lowest price target is $162, average price target is $220.85.

Most recent stock forecast was given by TAZEEN AHMAD from BAML on 01-Sep-2025. First documented stock forecast 22-Feb-2015.

Currently out of the existing stock ratings of ASND, 33 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$230

$25.95 (12.72%)

$216

1 months 8 days ago
(01-Sep-2025)

13/15 (86.67%)

$30.84 (15.49%)

259

Buy

$260

$55.95 (27.42%)

$254

1 months 21 days ago
(18-Aug-2025)

23/26 (88.46%)

$65.38 (33.59%)

150

Buy

$243

$38.95 (19.09%)

$207

2 months 29 days ago
(10-Jul-2025)

10/12 (83.33%)

$68.04 (38.89%)

779

Buy

$224

$19.95 (9.78%)

$180

3 months 27 days ago
(12-Jun-2025)

7/11 (63.64%)

$53.2 (31.15%)

754

Buy

$200

$-4.05 (-1.98%)

$200

4 months 28 days ago
(11-May-2025)

19/19 (100%)

$45.57 (29.51%)

347

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ASND (Ascendis Pharma AS) average time for price targets to be met?

On average it took 538.36 days on average for the stock forecasts to be realized with a an average price target met ratio 81.11

Which analyst has the current highest performing score on ASND (Ascendis Pharma AS) with a proven track record?

ANDREAS ARGYRIDES

Which analyst has the most public recommendations on ASND (Ascendis Pharma AS)?

Andreas Argyrides works at OPPENHEIMER and has 5 price targets and 5 ratings on ASND

Which analyst is the currently most bullish on ASND (Ascendis Pharma AS)?

Derek Archila with highest potential upside - $84.95

Which analyst is the currently most reserved on ASND (Ascendis Pharma AS)?

Tiago Fauth with lowest potential downside - -$115.05

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?